Form 4 Anika Therapeutics Inc For: 17 March
- Investing.com
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Anika Therapeutics Inc (ANIK)
Anika Therapeutics Inc stock price live, this page displays NASDAQ ANIK stock exchange data. View the ANIK premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Anika Therapeutics Inc real time stock price chart below.
What Is the Anika Therapeutics Inc Stock Price Today?
The Anika Therapeutics Inc stock price today is 15.28.
What Is the Stock Symbol for Anika Therapeutics Inc?
The stock ticker symbol for Anika Therapeutics Inc is ANIK.
Is ANIK the Same as $ANIK?
$ANIK is a common way to refer to the Anika Therapeutics Inc ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Anika Therapeutics Inc Trade On?
Anika Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Anika Therapeutics Inc a Good Stock to Buy?
Determining whether Anika Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Anika Therapeutics Inc share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ANIK quote. (ISIN: US0352551081)
What Is the Anika Therapeutics Inc Stock Price Today?
The Anika Therapeutics Inc stock price today is 15.28.
What Is the Stock Symbol for Anika Therapeutics Inc?
The stock ticker symbol for Anika Therapeutics Inc is ANIK.
Is ANIK the Same as $ANIK?
$ANIK is a common way to refer to the Anika Therapeutics Inc ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Anika Therapeutics Inc Trade On?
Anika Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Anika Therapeutics Inc a Good Stock to Buy?
Determining whether Anika Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Anika Therapeutics Inc share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ANIK quote. (ISIN: US0352551081)
NASDAQ
Currency in USD
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
15.12
15.58
52 wk Range
7.87
15.58
Trading near 52-week High
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
15.1215.58
52 wk Range
7.8715.58
Key Statistics
Edit
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
ANIK Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
17.50
Upside
+14.53%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Holds more cash than debt on its balance sheet
- Form 8K Anika Therapeutics Inc For: 26 February
- Investing.com
- Form 4 Anika Therapeutics Inc For: 17 March
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
Anika Therapeutics, Inc., a joint preservation company, focuses on early intervention orthopedics in the United States, Europe, and internationally. The company offers osteoarthritis (OA) pain management products and services, such as Monovisc and Orthovisc, which are single- and multi-injection, HA viscosupplement products indicated for pain relief from OA conditions, as well as Cingal, a non-opioid, single-injection OA pain management product; regenerative solutions, including an HA-based scaffold with bone and tendon fixation components and arthroscopic delivery instruments; Hyalofast, a resorbable scaffold used for single stage cartilage regeneration; and Tactoset injectable bone substitute, an HA-enhanced injectable bone repair therapy designed to treat insufficiency fractures and augment hardware fixation. It also provides Integrity, an HA-based scaffold with bone and tendon fixation components and arthroscopic delivery instruments; non-orthopedic products, including Hyvisc, a high molecular weight injectable HA veterinary product for the treatment of joint dysfunction in horses due to non-infectious synovitis associated with equine OA; Hyalobarrier, an anti-adhesion barrier indicated for use after abdominal-pelvic surgeries; and ophthalmic products; and Anikavisc and Nuvisc high molecular weight HA products. The company was founded in 1983 and is headquartered in Bedford, Massachusetts.
Anika Therapeutics Inc Earnings Call Summary for Q4/2025
- Q4 2025 EPS of $0.31 beat forecast by 321%, with revenue of $30.6M exceeding $29.1M estimate; stock rose 4.66% pre-market to $11.45
- Commercial channel surged 22% in Q4 while OEM declined 12%; Integrity product line doubled revenue with seven consecutive growth quarters
- GAAP gross margin improved to 63% from 56% YoY; adjusted EBITDA reached $4.5M, surpassing guidance despite flat overall revenue
- Company projects negative EPS initially for FY2026 quarters but expects improvement; anticipates continued commercial channel and Integrity growth
- Key risks include U.S. pricing pressures, international market uncertainties, regulatory approval delays, and potential supply chain disruptions
Last Updated: 02/26/2026, 09:21 AM
Read Full TranscriptAnika investor slides for Q4/2025
Last Update: Feb 26, 2026
See full investor slides
Compare ANIK to Peers and Sector
Metrics to compare | ANIK | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipANIKPeersSector | |
|---|---|---|---|---|
P/E Ratio | −20.5x | −20.7x | −0.5x | |
PEG Ratio | −0.26 | 0.42 | 0.00 | |
Price / Book | 1.4x | 1.5x | 2.6x | |
Price / LTM Sales | 1.8x | 1.9x | 3.2x | |
Upside (Analyst Target) | 13.3% | 19.8% | 45.7% | |
Fair Value Upside | Unlock | 3.8% | 4.8% | Unlock |
Analyst Ratings
2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 17.50
(+14.53% Upside)
Earnings
Latest Release
Feb 26, 2026
EPS / Forecast
0.31 / -0.14
Revenue / Forecast
30.6M / 29.1M
People Also Watch
FAQ
What Is the Anika (ANIK) Stock Price Today?
The Anika stock price today is 15.28 USD.
What Stock Exchange Does Anika Trade On?
Anika is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Anika?
The stock symbol for Anika is "ANIK."
What Is the Anika Market Cap?
As of today, Anika market cap is 203.83M USD.
What Is Anika's Earnings Per Share (TTM)?
The Anika EPS (TTM) is -0.70.
When Is the Next Anika Earnings Date?
Anika will release its next earnings report on May 07, 2026.
From a Technical Analysis Perspective, Is ANIK a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Anika Stock Split?
Anika has split 0 times.
How Many Employees Does Anika Have?
Anika has 235 employees.
What is the current trading status of Anika (ANIK)?
As of Apr 16, 2026, Anika (ANIK) is trading at a price of 15.28 USD, with a previous close of 15.30 USD. The stock has fluctuated within a day range of 15.12 USD to 15.58 USD, while its 52-week range spans from 7.87 USD to 15.58 USD.
What Is Anika (ANIK) Price Target According to Analysts?
The average 12-month price target for Anika is 17.50 USD, with a high estimate of 18 USD and a low estimate of 17 USD. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +14.53% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.